AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 9615816 — intervention group
Group type: COMPARATOR
Intervention: Wide excision with margins within 3 cm in 307 patients
Number of subjects: 612
Study 7642861 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil
Number of subjects: 136
Study 7642861 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 136
Study 2540786 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral administration of lisinopril (10 mg)
Number of subjects: 12
Study 2540786 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous administration of lisinopril (5 mg)
Number of subjects: 12
Study 345994 — intervention group
Group type: EXPERIMENTAL
Intervention: Lynestrenol (10 mg per day from the 10th to the 24th day of the cycle)
Number of subjects: 33
Study 345994 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 33
Study 31289060 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored approach in which probands decide which relatives to inform themselves and which to have informed by the genetic counsellor.
Number of subjects: 85
Study 31289060 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 85
Study 31289060 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored approach.
Number of subjects: 85
Study 27095035 — intervention group
Group type: EXPERIMENTAL
Intervention: Health promotion intervention program taught by trained teachers
Number of subjects: 464
Study 27095035 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 464
Study 25121567 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi‐Intervention Programme (MIP), 48 sessions, 16 weeks duration
Number of subjects: 61
Study 25121567 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi‐Intervention Programme (MIP)
Number of subjects: 61
Study 25121567 — intervention group
Group type: COMPARATOR
Intervention: Waiting list group (control)
Number of subjects: 61
Study 23768094 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet (specific details on dosage and duration not available)
Number of subjects: 0
Study 23768094 — intervention group
Group type: COMPARATOR
Intervention: Control group (specific details not available)
Number of subjects: 0
Study 21745357 — intervention group
Group type: EXPERIMENTAL
Intervention: Joint protection delivered by an occupational therapist (OT)
Number of subjects: 252
Study 21745357 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand exercises delivered by an occupational therapist (OT)
Number of subjects: 252
Study 21745357 — intervention group
Group type: EXPERIMENTAL
Intervention: Joint protection and hand exercises combined
Number of subjects: 252
Study 21745357 — intervention group
Group type: COMPARATOR
Intervention: Leaflet and advice
Number of subjects: 252
Study 19929112 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated Monte Carlo simulations
Number of subjects: 0
Study 19929112 — intervention group
Group type: COMPARATOR
Intervention: Pooling of data
Number of subjects: 0
Study 16876040 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% sodium hypochlorite (NaOCl) applied for 30 seconds before pulpotomy
Number of subjects: 18
Study 16876040 — intervention group
Group type: COMPARATOR
Intervention: Conventional calcium hydroxide pulpotomy (Control)
Number of subjects: 18
Study 14678133 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial prevention pacing ON
Number of subjects: 298
Study 14678133 — intervention group
Group type: COMPARATOR
Intervention: Atrial prevention pacing OFF
Number of subjects: 298
Study 11214014 — intervention group
Group type: EXPERIMENTAL
Intervention: Allopurinol (1 g)
Number of subjects: 27
Study 11214014 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 9381383 — intervention group
Group type: EXPERIMENTAL
Intervention: Lovastatin (40-60-80 mg daily)
Number of subjects: 42
Study 9381383 — intervention group
Group type: EXPERIMENTAL
Intervention: Lovastatin with plasmapheresis
Number of subjects: 42
Study 9381383 — intervention group
Group type: COMPARATOR
Intervention: Control group (no hypolipidemic therapy)
Number of subjects: 42
Study 8095854 — intervention group
Group type: EXPERIMENTAL
Intervention: GM‐CSF‐primed PBP and GM‐CSF (Group 2)
Number of subjects: 18
Study 8095854 — intervention group
Group type: COMPARATOR
Intervention: GM‐CSF alone (Group 1)
Number of subjects: 18
Study 8095854 — intervention group
Group type: EXPERIMENTAL
Intervention: PBP and GM‐CSF (Group 3)
Number of subjects: 18
Study 3094207 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term cyclosporine (CsA)
Number of subjects: 83
Study 3094207 — intervention group
Group type: COMPARATOR
Intervention: Conventional azathioprine and low-dose prednisolone (AP)
Number of subjects: 83
Study 3094207 — intervention group
Group type: COMPARATOR
Intervention: Control biopsies (day 0)
Number of subjects: 83
Study 3094207 — intervention group
Group type: COMPARATOR
Intervention: Biopsies several years after transplantation (AP therapy)
Number of subjects: 83
Study 30343314 — intervention group
Group type: EXPERIMENTAL
Intervention: AR-301 (human monoclonal antibody)
Number of subjects: 48
Study 30343314 — intervention group
Group type: COMPARATOR
Intervention: Placebo (buffer)
Number of subjects: 48
Study 26117081 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI) training workshop for alcohol SBI
Number of subjects: 20
Study 26117081 — intervention group
Group type: COMPARATOR
Intervention: No MI training (control group)
Number of subjects: 20
Study 23334785 — intervention group
Group type: EXPERIMENTAL
Intervention: 810-nm continuous wave low-level laser therapy (LLLT)
Number of subjects: 37
Study 23334785 — intervention group
Group type: COMPARATOR
Intervention: Placebo (no laser irradiation)
Number of subjects: 37
Study 22183484 — intervention group
Group type: EXPERIMENTAL
Intervention: budesonide/formoterol combination
Number of subjects: 10
Study 20207746 — intervention group
Group type: EXPERIMENTAL
Intervention: Programmable vibrating patient notifiers (PN ON)
Number of subjects: 356
Study 20207746 — intervention group
Group type: COMPARATOR
Intervention: Control group (PN OFF)
Number of subjects: 356
Study 20207746 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (PN ON and PN OFF)
Number of subjects: 356
Study 18562774 — intervention group
Group type: EXPERIMENTAL
Intervention: Rest with carbohydrate (CHO) supplementation (RCHO)
Number of subjects: 9
Study 18562774 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise with carbohydrate (CHO) supplementation (ECHO)
Number of subjects: 9
Study 18562774 — intervention group
Group type: COMPARATOR
Intervention: Rest with placebo (RPL)
Number of subjects: 9
Study 18562774 — intervention group
Group type: COMPARATOR
Intervention: Resistance exercise with placebo (EPL)
Number of subjects: 9
Study 16365224 — intervention group
Group type: EXPERIMENTAL
Intervention: Dornase alfa (2.5 mg)
Number of subjects: 24
Study 16365224 — intervention group
Group type: COMPARATOR
Intervention: Hypotonic saline solution (5 mL)
Number of subjects: 24
Study 11722829 — intervention group
Group type: EXPERIMENTAL
Intervention: Various smoking cessation interventions based on the Theory of Self‐Efficacy, Transtheoretical Model of Readiness for Change, and Theory of Addictions
Number of subjects: 0
Study 11722829 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 9604976 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate aqueous nasal spray (FPANS), 200 microg twice a day
Number of subjects: 34
Study 9604976 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate aqueous nasal spray, 200 microg twice a day
Number of subjects: 34
Study 9604976 — intervention group
Group type: COMPARATOR
Intervention: Placebo nasal spray
Number of subjects: 34
Study 7699845 — intervention group
Group type: EXPERIMENTAL
Intervention: SY5555 administered at daily doses between 3.4-10 mg/kg, t.i.d., for 3-14 days
Number of subjects: 45
Study 7699845 — intervention group
Group type: EXPERIMENTAL
Intervention: SY5555
Number of subjects: 45
Study 2773845 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron-folic acid supplements for 60 days
Number of subjects: 319
Study 2773845 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron supplementation
Number of subjects: 319
Study 2773845 — intervention group
Group type: EXPERIMENTAL
Intervention: Varying dosages of elemental iron
Number of subjects: 319
Study 2773845 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron supplementation for 4 and 8 months
Number of subjects: 319
Study 411668 — intervention group
Group type: EXPERIMENTAL
Intervention: Spironolactone (Aldactone) 400 mg/day
Number of subjects: 45
Study 411668 — intervention group
Group type: EXPERIMENTAL
Intervention: Spironolactone (Aldactone) 300 mg/day
Number of subjects: 45
Study 411668 — intervention group
Group type: EXPERIMENTAL
Intervention: Spironolactone (Aldactone) 200 mg/day
Number of subjects: 45
Study 411668 — intervention group
Group type: EXPERIMENTAL
Intervention: Spironolactone (Aldactone) 100 mg/day
Number of subjects: 45
Study 411668 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 29935537 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients who reported a perceived need for psychological care
Number of subjects: 444
Study 29935537 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with higher 4DSQ distress scores
Number of subjects: 444
Study 29935537 — intervention group
Group type: COMPARATOR
Intervention: GPs with lower confidence in identifying depression
Number of subjects: 444
Study 27087294 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse triage intervention
Number of subjects: 7012
Study 27087294 — intervention group
Group type: COMPARATOR
Intervention: Nurse practitioners
Number of subjects: 7012
Study 27087294 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurses with less perceived preparedness for triage
Number of subjects: 7012
Study 24881829 — intervention group
Group type: EXPERIMENTAL
Intervention: iOS application (app) for contraceptive counseling
Number of subjects: 60
Study 24881829 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 60
Study 21967490 — intervention group
Group type: EXPERIMENTAL
Intervention: Posaconazole 200mg once daily for 24 weeks
Number of subjects: 218
Study 21967490 — intervention group
Group type: EXPERIMENTAL
Intervention: Posaconazole 400mg once daily for 24 weeks
Number of subjects: 218
Study 21967490 — intervention group
Group type: EXPERIMENTAL
Intervention: Posaconazole 400mg once daily for 12 weeks
Number of subjects: 218
Study 21967490 — intervention group
Group type: COMPARATOR
Intervention: Terbinafine 250mg once daily for 12 weeks
Number of subjects: 218
Study 21967490 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 24 weeks
Number of subjects: 218
Study 20403470 — intervention group
Group type: EXPERIMENTAL
Intervention: ST-segment recovery algorithms (summed ST-segment deviation resolution, single-lead STD resolution, worst-lead residual STD)
Number of subjects: 144
Study 20403470 — intervention group
Group type: EXPERIMENTAL
Intervention: Worst-lead residual STD
Number of subjects: 144
Study 18696099 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% NCT plus 0.1% NH(4)Cl
Number of subjects: 34
Study 18696099 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% NCT plus 0.1% NH(4)Cl
Number of subjects: 34
Study 18696099 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% NCT plus 1% NH(4)Cl
Number of subjects: 34
Study 18696099 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline
Number of subjects: 34
Study 18696099 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 34
Study 15802774 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisphosphonates (first-line drugs)
Number of subjects: 0
Study 15802774 — intervention group
Group type: EXPERIMENTAL
Intervention: Active vitamin D3 and vitamin K2 (second-line drugs)
Number of subjects: 0
Study 11867376 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective spinal anesthesia (SSA)
Number of subjects: 20
Study 11867376 — intervention group
Group type: COMPARATOR
Intervention: Desflurane anesthesia (DES)
Number of subjects: 20
Study 11867376 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective spinal anesthesia (SSA) and Desflurane anesthesia (DES)
Number of subjects: 20
Study 10320242 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive operation (L-shaped sternotomy)
Number of subjects: 120
Study 10320242 — intervention group
Group type: COMPARATOR
Intervention: Conventional operation
Number of subjects: 120
Study 8730517 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 min deprivation
Number of subjects: 117
Study 8730517 — intervention group
Group type: EXPERIMENTAL
Intervention: 90 min deprivation
Number of subjects: 117
Study 8730517 — intervention group
Group type: EXPERIMENTAL
Intervention: 180 min deprivation
Number of subjects: 117
Study 8730517 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking cues exposure
Number of subjects: 117
Study 8730517 — intervention group
Group type: EXPERIMENTAL
Intervention: Cue exposure
Number of subjects: 117
Study 1713930 — intervention group
Group type: EXPERIMENTAL
Intervention: Gelatin (Group 2)
Number of subjects: 30
Study 1713930 — intervention group
Group type: COMPARATOR
Intervention: Ringer's lactate (Group 1)
Number of subjects: 30
Study 1713930 — intervention group
Group type: COMPARATOR
Intervention: Dextran 40 (Group 3)
Number of subjects: 30
Study 1713930 — intervention group
Group type: EXPERIMENTAL
Intervention: C3 and C4 components of complement
Number of subjects: 30
Study 7119652 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-smoking advice (intervention group, 714 men)
Number of subjects: 1445
Study 7119652 — intervention group
Group type: COMPARATOR
Intervention: Normal care (control group, 731 men)
Number of subjects: 1445
Study 7119652 — intervention group
Group type: EXPERIMENTAL
Intervention: Total deaths (intervention group, 714 men)
Number of subjects: 1445
Study 31358336 — intervention group
Group type: EXPERIMENTAL
Intervention: del Nido (DN) cardioplegia
Number of subjects: 150
Study 31358336 — intervention group
Group type: COMPARATOR
Intervention: cold blood (CB) cardioplegia
Number of subjects: 150
Study 30530975 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 μg bryostatin
Number of subjects: 150
Study 30530975 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 μg bryostatin
Number of subjects: 150
Study 30530975 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study 27339779 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined nutraceuticals (artichoke, red yeast rice, banaba, coenzyme Q10)
Number of subjects: 30
Study 27339779 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 25623412 — intervention group
Group type: EXPERIMENTAL
Intervention: SBIRT intervention (online Screening, Brief Intervention, and Referral to Treatment)
Number of subjects: 263
Study 25623412 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (control group)
Number of subjects: 263
Study 24890141 — intervention group
Group type: EXPERIMENTAL
Intervention: KumaFix fixation system (treatment group, n = 23)
Number of subjects: 45
Study 24890141 — intervention group
Group type: COMPARATOR
Intervention: Traditional U‐shaped pedicle screw (control group, n = 22)
Number of subjects: 45
Study 22571474 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic therapy (VSL#3), n=31
Number of subjects: 63
Study 22571474 — intervention group
Group type: COMPARATOR
Intervention: Placebo, n=32
Number of subjects: 63
Study 20602781 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin 300 mg daily
Number of subjects: 2757
Study 20602781 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin 450 mg daily
Number of subjects: 2757
Study 20602781 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin 600 mg daily
Number of subjects: 2757
Study 20602781 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2757
Study 17613582 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosocial intervention (up to 16 meetings over six months, approximately weekly for 12 weeks, followed by tri-weekly sessions for another 12 weeks, lasting approximately 1 hour each)
Number of subjects: 291
Study 17613582 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosocial intervention
Number of subjects: 291
Study 17613582 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 291
Study 16097635 — intervention group
Group type: EXPERIMENTAL
Intervention: D2 receptor binding in the caudate nucleus and putamen in the PD-JPD group
Number of subjects: 24
Study 16097635 — intervention group
Group type: EXPERIMENTAL
Intervention: D2 receptor binding in the putamen in the MSA-PSP group
Number of subjects: 24
Study 16097635 — intervention group
Group type: COMPARATOR
Intervention: D2 receptor binding in the PD-JPD group
Number of subjects: 24
Study 16097635 — intervention group
Group type: COMPARATOR
Intervention: D2 receptor binding in the MSA-PSP group
Number of subjects: 24
Study 12033702 — intervention group
Group type: EXPERIMENTAL
Intervention: Red wine (250 ml, approximately 23 g of ethanol) with the noon meal
Number of subjects: 13
Study 10091726 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraperitoneal hyperthermic chemoperfusion (IHCP) combined with surgery
Number of subjects: 141
Study 10091726 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone (control group)
Number of subjects: 141
Study 7576329 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention community (STD treatment)
Number of subjects: 12534
Study 7576329 — intervention group
Group type: COMPARATOR
Intervention: Comparison community (no STD treatment)
Number of subjects: 12534
Study 1976051 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenoterol
Number of subjects: 12
Study 1976051 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoproterenol
Number of subjects: 12
Study 1976051 — intervention group
Group type: EXPERIMENTAL
Intervention: Albuterol
Number of subjects: 12
Study 1976051 — intervention group
Group type: COMPARATOR
Intervention: Ipratropium bromide
Number of subjects: 12
Study 6980774 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg tilcotil (Ro 12-0068) daily
Number of subjects: 6
Study 6980774 — intervention group
Group type: COMPARATOR
Intervention: 900 mg aspirin 4-times daily
Number of subjects: 6
Study 30779246 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.03% chlorhexidine and 0.05% cetylpyridinium chloride mouth rinse
Number of subjects: 54
Study 30779246 — intervention group
Group type: COMPARATOR
Intervention: Placebo mouth rinse
Number of subjects: 54
Study 29150250 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine 5mg + Losartan 100mg + Rosuvastatin 20mg (A/L/R 5/100/20)
Number of subjects: 146
Study 29150250 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine 5mg + Losartan 100mg (A/L 5/100)
Number of subjects: 146
Study 29150250 — intervention group
Group type: COMPARATOR
Intervention: Losartan 100mg + Rosuvastatin 20mg (L/R 100/20)
Number of subjects: 146
Study 25645108 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab with adjuvant radiotherapy (B-RT)
Number of subjects: 39
Study 25645108 — intervention group
Group type: COMPARATOR
Intervention: Adjuvant radiotherapy alone (RT)
Number of subjects: 39
Study 24943855 — intervention group
Group type: COMPARATOR
Intervention: 3 mg/kg 0.5% prilocaine
Number of subjects: 45
Study 24943855 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mg/kg 0.5% prilocaine plus 50 mg dexketoprofen
Number of subjects: 45
Study 24943855 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mg/kg 0.5% prilocaine plus 8 mg dexamethasone
Number of subjects: 45
Study 19084088 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenofibrate treatment
Number of subjects: 0
Study 15103506 — intervention group
Group type: EXPERIMENTAL
Intervention: Sentinel lymph node biopsy using (99m)Tc‐labelled colloids with particles in the 100‐200 nm size range.
Number of subjects: 0
Study 15103506 — intervention group
Group type: EXPERIMENTAL
Intervention: Lymphoscintigraphy for sentinel node detection.
Number of subjects: 0
Study 10836288 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram (highly selective serotonin uptake inhibitor)
Number of subjects: 4004
Study 10836288 — intervention group
Group type: EXPERIMENTAL
Intervention: TTCAs (adrenergic tetracyclic antidepressants)
Number of subjects: 4004
Study 10836288 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4004
Study 9342579 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg valsartan, once-daily for 8 days
Number of subjects: 16
Study 8348204 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenobarbital
Number of subjects: 0
Study 8348204 — intervention group
Group type: COMPARATOR
Intervention: Clonazepam
Number of subjects: 0
Study 8348204 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzodiazepines (Clonazepam)
Number of subjects: 0
Study 8348204 — intervention group
Group type: COMPARATOR
Intervention: Barbiturates (Phenobarbital)
Number of subjects: 0
Study 2878607 — intervention group
Group type: EXPERIMENTAL
Intervention: Nizatidine
Number of subjects: 43
Study 2878607 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study 31831062 — intervention group
Group type: EXPERIMENTAL
Intervention: Metastasectomy
Number of subjects: 65
Study 31831062 — intervention group
Group type: COMPARATOR
Intervention: Control (active monitoring)
Number of subjects: 65
Study 27921517 — intervention group
Group type: EXPERIMENTAL
Intervention: 17 alpha-hydroxyprogesterone caproate (17-OHPC) weekly injections, full compliance (100%)
Number of subjects: 405
Study 27921517 — intervention group
Group type: EXPERIMENTAL
Intervention: 17 alpha-hydroxyprogesterone caproate (17-OHPC) weekly injections, partial compliance (40-80%)
Number of subjects: 405
Study 27921517 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 405
Study 27921517 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of odds ratios between groups
Number of subjects: 405
Study 26100607 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-wide intervention (CWI) promoting physical activity (PA)
Number of subjects: 4414
Study 26100607 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexibility activity promotion (Group FM)
Number of subjects: 4414
Study 26100607 — intervention group
Group type: COMPARATOR
Intervention: Aerobic activity promotion (Group A)
Number of subjects: 4414
Study 26100607 — intervention group
Group type: COMPARATOR
Intervention: Aerobic, flexibility, and muscle-strengthening activities promotion (Group AFM)
Number of subjects: 4414
Study 26100607 — intervention group
Group type: COMPARATOR
Intervention: All groups for pain outcomes
Number of subjects: 4414